Literature DB >> 8162477

Classification of clinical subsets in psoriatic arthritis.

D Veale1, S Rogers, O Fitzgerald.   

Abstract

The classification of PsA is controversial. Two recent papers have suggested new subgroup classifications, however both have served only to expand the controversy. In this study the clinical and radiologic features of 100 patients with PsA are recorded in order to examine possible clinical or radiologic features which may be associated with functional disability and to examine the usefulness of recent reclassification proposals in our patient population. Results indicate that an asymmetric oligoarthritis (AO) pattern of disease is most common occurring in 43%. A symmetric polyarthritis (SP) was present in 33%, and this subgroup had the highest number of erosions and deformities, and a higher proportion of patients with grade III/IV ARA functional disability. While the DIP joints were involved in 46%, predominant DIP joint disease occurred in 16%. As the DIP group had the shortest duration of arthritis, it may be that this group represents recent onset PsA which will evolve into one of the other subgroups. Sacroiliitis was a feature in 14% with predominant spondylitis (SPON) in 4%. Arthritis mutilans (AM) was rare occurring in only 2% of this population, perhaps representing patients with end-stage SP disease. Finally, 2% of patients had features of the synovitis-acne-pustulosis-hyperostosis-osteomyelitis (SAPHO) syndrome. A classification comprising just three subgroups (AO, SP, SPON) is proposed as being of most use clinically though a long-term prospective study is needed for verification.

Entities:  

Mesh:

Year:  1994        PMID: 8162477     DOI: 10.1093/rheumatology/33.2.133

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  42 in total

Review 1.  Seronegative spondyloarthropathies: to lump or split?

Authors:  P Nash; P J Mease; J Braun; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

2.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

3.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-03-04       Impact factor: 2.631

4.  Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Ahmet Gul; Lale Ocal; Meral Konice; Orhan Aral; Murat Inanc
Journal:  Rheumatol Int       Date:  2008-09-03       Impact factor: 2.631

5.  Innovations in Psoriasis Management: Based on Selected Presentations from the Symposium for Cosmetic Advances & Laser Education (SCALE) Virtual Congress-July 24 to 26, 2020.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

6.  The spectrum of psoriatic arthritis in a South African cohort.

Authors:  Jean-Paul Muzemb Kanyik; Annibale Coi; Asgar Ali Kalla
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

Review 7.  Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

Authors:  Tai Teck Leong; Ursula Fearon; Douglas J Veale
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

8.  Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis.

Authors:  Rubens Bonfiglioli; Roseneide A Conde; Percival D Sampaio-Barros; Paulo Louzada-Junior; Eduardo A Donadi; Manoel B Bertolo
Journal:  Clin Rheumatol       Date:  2007-11-03       Impact factor: 2.980

9.  Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations.

Authors:  Mariam Ghozzi; Wahiba Sakly; Amani Mankaï; Elyes Bouajina; Fethi Bahri; Rafiaa Nouira; Chedia Kechrid; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2013-12-01       Impact factor: 2.631

10.  Dactylitis in psoriatic arthritis: a marker for disease severity?

Authors:  J E Brockbank; M Stein; C T Schentag; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.